Searched for
METFORMIN HCL
After long phase of consolidation: 4 Indian pharma stocks with upside potential of up to 41%Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...12 Dec, 2023, 12.43 PM IST- New tailwinds emerge! 5 midcap pharma stocks with upside potential of up to 37%If one looks at corporate announcements, a large number of small and mid-caps pharma companies are announcing one or the other thing either...05 Nov, 2023, 12.54 PM IST
- Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising ...23 Oct, 2023, 01.39 PM IST
- Second & better attempt; 5 Indian pharma stocks with upside potential of up to 31%Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performa...11 Oct, 2023, 11.00 AM IST
- Weekly Top Picks: 4 stocks with consistent score improvement & upside potential of up to 68%Is the up move of Nifty on friday, a dead cat bounce or it is the start of a sustainable rally. Rather than worrying about it is better to ...01 Apr, 2023, 12.12 PM IST
- Sun Pharma recalls 50,868 bottles of diabetes drug in USDrug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to th...21 May, 2021, 04.32 PM IST
- Sun Pharma, Alembic recall products in US marketAccording to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.18 Apr, 2021, 11.47 AM IST
- Bet on L&T and midcaps like KEC to play the Atmanirbhar theme: Chakri LokapriyaInfrastructure has a huge multiplier effect because if you are laying a road from Delhi to Mumbai and you are creating jobs all around the ...17 Aug, 2020, 07.03 PM IST
- Branded heart, diabetes drugs much costlier than generic onesIn the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic dr...10 Mar, 2017, 04.50 PM IST
- Zydus Cadila gets USFDA nod for anti-diabetics tabletsDrug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in th...01 Mar, 2016, 01.41 PM IST
- Lupin launches generic diabetes drug in the USLupin has launched 10 products in the US this fiscal year and has received approvals for 21 from the FDA. The drug maker has 35 FTF product...02 Feb, 2016, 08.01 PM IST
- Government caps price of 6 formulations packsDrug firms such as Abbott Healthcare, Ipca Laboratories and Merck would be impacted by National Pharmaceutical Pricing Authority's (NPPA) m...12 Nov, 2015, 10.02 PM IST
- Pharma pricing authority NPPA puts cap on 18 formulations packs’ pricesFirms such as Cipla, Alembic Pharma and Unichem Laboratories will be impacted by the government's move for prices fixation and revision.02 Nov, 2015, 04.00 AM IST
- Lupin gets USFDA nod for diabetes drugLupin has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets in US market.22 Jul, 2013, 04.57 PM IST
- Sun Pharma hits fresh record high, market cap exceeds Rs 1 lakh croreM-cap of Sun Pharma exceeded Rs 1 lakh cr and exceeds total value of DRL, Lupin & Cipla. Sun Pharma is now the 14th most valuable co.07 May, 2013, 04.57 PM IST
- Lupin gets USFDA approval for diabetes drugLupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in tr...30 Jan, 2012, 06.42 PM IST
- Ranbaxy gets USFDA nod for diabetic drugDrug maker Ranbaxy's wholly-owned US subsidiary receives USFDA approval to market Metformin Hydrochloride tablets.13 Aug, 2007, 11.35 AM IST
Load More
